Results 221 to 230 of about 115,201 (249)

Activated T cells and cytokine-induced CD3 + CD56 + killer cells

Annals of Hematology, 1997
Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor ...
G D, Schmidt-Wolf, R S, Negrin, I G, Schmidt-Wolf   +2 more
openaire   +2 more sources

Cytokine Induced Killer (CIK) cells for the treatment of haematological neoplasms

Immunology Letters, 2013
Cytokine Induced Killer (CIK) cells are in vitro activated human CD8 T cells which have maintained several characteristics of T-EMRA cells and additionally acquired non specific anti tumoral cytotoxicity and CD56 overexpression, thus representing a cell population with double T and NK phenotype.
M, Introna, J, Golay, A, Rambaldi
openaire   +2 more sources

Clinical expansion of cytokine induced killer (CIK) cells

ISBT Science Series, 2012
Cytokine induced killer (CIK) cells are polyclonal T cells that can be expanded from marrow or peripheral blood lymphocytes with potent non‐MHC‐restricted cytotoxicity against a variety of tumor target cells. Earlier work had established the superiority of CIK cells over LAK cells in terms expansion and cytotoxicity.
M. B. C. Koh, Y. Ching Linn
openaire   +1 more source

Ultrastructure of cytokine induced human natural killer cells

Cytotherapy, 2019
Background & Aim Natural Killer (NK) cells account for 3.66-26.74% of lymphocytes in the human peripheral blood. They secrete exosomes which express both NK-cell markers and cytokines. It has been shown that Interkin-2 (IL-2) stimulated the proliferation of natural killer cells, a sub-class of lymphocytes in human.
W. Ng, D. Tam, D. Liao, W. Lee, F. Chan
openaire   +1 more source

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

Cancers, 2020
Manuel Ritter, Jörg Ellinger
exaly  

Cytokine-induced-killer-cell-therapy

Reactions Weekly
openaire   +2 more sources

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study

Cancer Immunology, Immunotherapy, 2012
Xiubao Ren, Hui Li, Jinpu Yu
exaly  

Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma

Archives of Pharmacal Research, 2014
Youngsoo Kim, Sang-Bae Han, Jin Tae Hong   +2 more
exaly  

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

Cytotherapy, 2009
Hui Li, Feng Wei, Jinpu Yu
exaly  

CYTOKINE-INDUCED KILLER CELLS

2022
openaire   +1 more source